<DOC>
	<DOCNO>NCT01195506</DOCNO>
	<brief_summary>Vascular endothelial growth factor ( VEGF ) -C recognize tumor lymphangiogenic factor base effect activate VEGFR3 lymphatic endothelial cell . VEGFR3 propose specific marker lymphatic endothelial cell . Recent study indicate VEGFR3 also express variety human malignancy , include lung , colon rectal , head neck cancer . Moreover , VEGF-C/VEGFR3 axis demonstrate regulate angiogenesis , cell invasion , metastasis several solid tumor . The promotion cell mobility response VEGF-C require involvement adhesion molecule contactin-1 . In addition solid tumor , report VEGF-C/VEGFR3 axis activate subset leukemia patient . Until , demonstrate higher endogenous VEGFC level acute myelogenous leukemia ( AML ) cell relate decreased vitro vivo responsiveness chemotherapy ; effect may result inhibition apoptosis increase Bcl-2/Bax ratio VEGF-C/VEGFR3 pathway . Thus , functional VEGF-C/VEGFR3 system may exist leukemia . However , detail information concern role VEGF-C/VEGFR3 non-solid tumor still lack . Bone marrow neoangiogenesis play crucial pathogenic possible prognostic role AML . The VEGF-C/VEGFR3 axis prove regulation solid tumor angiogenesis . In investigator preliminary study , investigator find VEGF-C may play critical role angiogenesis regulation leukemic cell upregulating cyclooxygenase-2 ( COX-2 ) . Furthermore , investigator find upregulation COX-2 also correlate VEGF-C-induced proliferation leukemic cell phenomenon might regulate chemoresistance VEGF-C . In study , investigator investigate extent angiogenesis chemoresistance induce VEGF-C leukemic cell . This study provide evidence subject novel role VEGF-C leukemia . With progress molecular biology VEGF-C , value therapeutic target highly promising .</brief_summary>
	<brief_title>Study Novel Functions Molecular Mechanisms Vascular Endothelial Growth Factor-C ( VEGF-C ) Acute Myeloid Leukemia ( AML )</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>patient diagnose acute myeloid leukemia patient diagnose type leukemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>We Will Collect Bone Marrow Specimens From AML Patients</keyword>
</DOC>